Indaptus Therapeutics, Inc. - 10-Q Filing

Indaptus Therapeutics reports Q3 2026 results with 153.6 million common shares outstanding as of November 13, 2026.

SEC EDGAR · November 13, 2026, 13:30 UTC

Tickers: $INDP

More Regulatory news

Evolution Metals & Technologies Corp. - 8-K Filing SEC EDGAR · November 13, 2026, 13:38 UTC
Virgin Galactic Holdings, Inc - 8-K Filing SEC EDGAR · November 13, 2026, 13:39 UTC
Suncrete, Inc. - 8-K Filing SEC EDGAR · November 13, 2026, 13:36 UTC
Xenetic Biosciences, Inc. - 8-K Filing SEC EDGAR · November 13, 2026, 13:35 UTC
TANDEM DIABETES CARE INC - 8-K Filing SEC EDGAR · November 13, 2026, 13:35 UTC
COMMVAULT SYSTEMS INC - 8-K Filing SEC EDGAR · November 13, 2026, 13:30 UTC
Katapult Holdings, Inc. - 10-Q Filing SEC EDGAR · November 13, 2026, 13:30 UTC
GOODYEAR TIRE & RUBBER CO /OH/ - 8-K Filing SEC EDGAR · November 13, 2026, 13:30 UTC
BIO KEY INTERNATIONAL INC - 8-K Filing SEC EDGAR · November 13, 2026, 13:30 UTC
Loop Industries, Inc. - 8-K Filing SEC EDGAR · November 13, 2026, 13:30 UTC